F&V Capital Management LLC Purchases 1,590 Shares of CVS Health Co. (NYSE:CVS)

F&V Capital Management LLC increased its position in CVS Health Co. (NYSE:CVS) by 1.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 133,539 shares of the pharmacy operator’s stock after acquiring an additional 1,590 shares during the quarter. CVS Health comprises about 3.1% of F&V Capital Management LLC’s investment portfolio, making the stock its 13th biggest position. F&V Capital Management LLC’s holdings in CVS Health were worth $10,651,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Norges Bank acquired a new stake in CVS Health in the 4th quarter valued at approximately $1,092,040,000. Capital International Investors raised its stake in CVS Health by 47.4% during the 4th quarter. Capital International Investors now owns 33,691,698 shares of the pharmacy operator’s stock valued at $2,660,298,000 after purchasing an additional 10,837,801 shares during the last quarter. Clearbridge Investments LLC boosted its holdings in CVS Health by 306.6% in the 4th quarter. Clearbridge Investments LLC now owns 3,046,216 shares of the pharmacy operator’s stock valued at $240,529,000 after purchasing an additional 2,297,100 shares during the period. Junto Capital Management LP acquired a new stake in CVS Health in the 4th quarter worth $111,209,000. Finally, International Assets Investment Management LLC increased its holdings in shares of CVS Health by 8,697.2% during the 4th quarter. International Assets Investment Management LLC now owns 1,322,129 shares of the pharmacy operator’s stock worth $104,395,000 after purchasing an additional 1,307,100 shares during the period. 80.66% of the stock is currently owned by institutional investors.

Insider Activity at CVS Health

In related news, Director Edward J. Ludwig purchased 1,000 shares of the business’s stock in a transaction dated Thursday, May 2nd. The shares were bought at an average price of $53.88 per share, with a total value of $53,880.00. Following the purchase, the director now directly owns 21,630 shares in the company, valued at approximately $1,165,424.40. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.24% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

CVS has been the topic of several research reports. Robert W. Baird started coverage on CVS Health in a research note on Thursday, May 30th. They set a “neutral” rating and a $61.00 price target on the stock. Leerink Partnrs lowered CVS Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, May 1st. Baird R W upgraded shares of CVS Health to a “hold” rating in a research note on Thursday, May 30th. Bank of America lowered their target price on shares of CVS Health from $95.00 to $77.00 and set a “buy” rating on the stock in a research note on Thursday, May 2nd. Finally, Piper Sandler upped their price objective on CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a research note on Friday, March 15th. Eleven investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $75.05.

CVS Health Trading Up 0.3 %

NYSE:CVS traded up $0.19 during trading hours on Wednesday, hitting $60.63. 8,197,643 shares of the stock were exchanged, compared to its average volume of 12,049,123. The company’s 50 day moving average is $60.16 and its two-hundred day moving average is $70.45. The company has a market capitalization of $76.11 billion, a P/E ratio of 10.66, a price-to-earnings-growth ratio of 0.58 and a beta of 0.53. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25. The company has a quick ratio of 0.61, a current ratio of 0.81 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.69 by ($0.38). CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The firm had revenue of $88.44 billion during the quarter, compared to the consensus estimate of $89.33 billion. During the same quarter in the prior year, the business earned $2.20 EPS. CVS Health’s revenue was up 3.7% on a year-over-year basis. On average, sell-side analysts anticipate that CVS Health Co. will post 7.02 earnings per share for the current fiscal year.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.